Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Horiuchi

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
International Journal of Cardiology|October 19, 2025
Real-world data and its clinical relevance: Complementing randomized controlled trialsYu Horiuchi, Nicholas Wettersten
Journal of Cardiology|June 24, 2024
Treatment strategies for diuretic resistance in patients with heart failureYu Horiuchi, Nicholas Wettersten
Faculty Reviews|May 12, 2021
Advancements in biomarkers for cardiovascular disease: diagnosis, prognosis, and therapyNicholas Wettersten, Yu Horiuchi, Alan Maisel
Circulation|February 22, 2021
Response by Horiuchi et al to Letter Regarding Article, "Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction"Yu Horiuchi, Nicholas Wettersten, Alan Maisel
International Journal of Cardiology|January 27, 2025
A comprehensive impact of GLP1Ras on CKM syndromeYu Horiuchi, Nicholas Wettersten, Kengo Tanabe
Internal Medicine (Tokyo, Japan)|September 21, 2021
Black Esophagus with Acute Aortic DissectionYu Horiuchi, Nobuo Toda, Kengo Tanabe
Heart and Vessels|November 25, 2025
Reply to letter to the editor: Pericoronary adipose tissue in cardiac remodeling: a bystander or participant?Mai Katsura, Yu Horiuchi, Kengo Tanabe
Oxford Medical Case Reports|February 26, 2026
Reversible massive ascites from amiodarone hepatotoxicityYohei Nishimura, Yu Horiuchi, Kengo Tanabe
Heart International|February 6, 2023
Natriuretic Peptide-guided Therapy for Heart FailureYu Horiuchi, Humberto Villacorta, Alan S Maisel
Diabetes, Obesity & Metabolism|March 27, 2026
Real-World Cardiovascular Outcomes of Obesity Treatment With Tirzepatide Versus Semaglutide in Non-Diabetic AdultsMai Katsura, Yu Horiuchi, Kengo Tanabe, et al.
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
International Journal of Cardiology|October 19, 2025
Real-world data and its clinical relevance: Complementing randomized controlled trialsYu Horiuchi, Nicholas Wettersten
Journal of Cardiology|June 24, 2024
Treatment strategies for diuretic resistance in patients with heart failureYu Horiuchi, Nicholas Wettersten
Faculty Reviews|May 12, 2021
Advancements in biomarkers for cardiovascular disease: diagnosis, prognosis, and therapyNicholas Wettersten, Yu Horiuchi, Alan Maisel
Circulation|February 22, 2021
Response by Horiuchi et al to Letter Regarding Article, "Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction"Yu Horiuchi, Nicholas Wettersten, Alan Maisel
International Journal of Cardiology|January 27, 2025
A comprehensive impact of GLP1Ras on CKM syndromeYu Horiuchi, Nicholas Wettersten, Kengo Tanabe
Internal Medicine (Tokyo, Japan)|September 21, 2021
Black Esophagus with Acute Aortic DissectionYu Horiuchi, Nobuo Toda, Kengo Tanabe
Heart and Vessels|November 25, 2025
Reply to letter to the editor: Pericoronary adipose tissue in cardiac remodeling: a bystander or participant?Mai Katsura, Yu Horiuchi, Kengo Tanabe
Oxford Medical Case Reports|February 26, 2026
Reversible massive ascites from amiodarone hepatotoxicityYohei Nishimura, Yu Horiuchi, Kengo Tanabe
Heart International|February 6, 2023
Natriuretic Peptide-guided Therapy for Heart FailureYu Horiuchi, Humberto Villacorta, Alan S Maisel
Diabetes, Obesity & Metabolism|March 27, 2026
Real-World Cardiovascular Outcomes of Obesity Treatment With Tirzepatide Versus Semaglutide in Non-Diabetic AdultsMai Katsura, Yu Horiuchi, Kengo Tanabe, et al.
Pageof 12